journal article·2018-10-31Open access

Nano-gold displayed anti-inflammatory property via NF-kB pathways by suppressing COX-2 activity

Mahmood Ahmad Khan, Mohd Jahir Khan

Abstract

Rheumatoid arthritis (RA) is an autoimmune inflammatory disease, affecting almost 1% of world population. Although the exact cause of RA is not known but the complex interaction between inflammatory mediators like tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), cyclooxygenase-2 (COX-2) and nitric oxide (NO) is accountable for cartilage destruction in joints. Gold is used for arthritis treatment since long without knowing its mechanism of action. Hence, the present study was designed to assess antiarthritic activity of nanogold (AuNGs) in collagen-induced arthritic (CIA) rat model by virtue of decreasing inflammatory mediators and oxidative stress. After induction CIA rats were treated with AuNGs in phosphate buffer at a dose of 20 μg/kg body weight for 20 days and found a significant decrease in the level of inflammatory mediators like TNF-α, IL-1β, COX-2 and transcription factor NF-kB (Nuclear factor-kB), which was found to be elevated in CIA rats. Additionally imbalance in oxidant and antioxidant status were determined and perceived that AuNGs remarkably attenuates the imbalance in level of antioxidant and oxidant near to normal. In consistent to biochemical results, mRNA expression of NF-kB, TNF-α, COX-2, and iNOS were also up-regulated in CIA rats, which were considerably down regulated by AuNGs treatment. These findings were positively correlated with the histological results of joints, displayed reduced inflammation and bone erosion in treated group. This study demonstrates the ability of AuNGs to ameliorate production of inflammatory mediators and oxidative stress in CIA rats. Induction of arthritis in rats showed increased inflammation, which activate the transcription factor NF-kB through activation of of IkB kinases (IKK) and ubiquination/proteosome degradation of IKB and transportation of activated NF-kB from cytoplasm to nucleus. In nucleus activated NF-kB bind to the promoter region of target gene and up regulate the production of pro-inflammatory cytokines, COX-2 and other inflammatory mediators that leads to cartilage destruction. AuNGs inhibit the activation of NF-kB and other inflammatory mediators and attenuate inflammation and cartilage destruction. COX-2: cyclooxygenase-2; IKK: IkB kinases; IKB: I Kappa B; IL-1β: interleukin-6; IL-6: interleukin-6; iNOS: inducible nitric oxide synthase; NF-kB: nuclear transcription factor kappa B; ROS: reactive oxygen species; TNF-α: tumour necrosis factor-alpha.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Rheumatoid Arthritis Research and Therapies · Bone Metabolism and Diseases · Osteoarthritis Treatment and Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biochemistry, University College of Medical Sciences & GTB Hospital

School of Biotechnology, Jawaharlal Nehru University

Funding

University Grants Commission

References (57)

Show source-provided references
1. 10.1056/NEJM20010322344120710.1056/NEJM200103223441207 ↗
2. 10.1111/j.1742-4658.2008.06580.x10.1111/j.1742-4658.2008.06580.x ↗
3. 10.1002/art.3809510.1002/art.38095 ↗
4. 10.1172/JCI11952610.1172/JCI119526 ↗
5. 10.1101/cshperspect.a00165110.1101/cshperspect.a001651 ↗
6. 10.1038/sigtrans.2017.2310.1038/sigtrans.2017.23 ↗
7. 10.1016/j.bcp.2006.08.00710.1016/j.bcp.2006.08.007 ↗
8. 10.1021/ja01173a06110.1021/ja01173a061 ↗
9. 10.1097/00000441-195102000-0000910.1097/00000441-195102000-00009 ↗
10. 10.1038/nrd110910.1038/nrd1109 ↗
11. 10.1056/NEJMct05518310.1056/NEJMct055183 ↗
12. 10.1080/10826068.2013.83573210.1080/10826068.2013.835732 ↗
13. 10.1088/0957-4484/22/45/45570810.1088/0957-4484/22/45/455708 ↗
14. 10.1080/21691401.2018.143165310.1080/21691401.2018.1431653 ↗
15. 10.1364/OE.18.00326410.1364/OE.18.003264 ↗
16. Sokolov K, Follen M, Aaron J, et al. Real-time vital optical imaging of precancer using antiepidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res. 2003;63:1999–2004.
17. 10.1021/nl049523l10.1021/nl049523l ↗
18. 10.1021/ja048726910.1021/ja0487269 ↗
19. 10.1021/ja711298b10.1021/ja711298b ↗
20. 10.1016/j.bios.2006.04.03110.1016/j.bios.2006.04.031 ↗
21. 10.1080/21691401.2018.143058510.1080/21691401.2018.1430585 ↗
22. 10.1021/nl050074e10.1021/nl050074e ↗
23. 10.1021/ac702037y10.1021/ac702037y ↗
24. 10.1080/21691401.2017.130539310.1080/21691401.2017.1305393 ↗
25. 10.1080/21691401.2017.141405410.1080/21691401.2017.1414054 ↗
26. 10.3109/21691401.2014.95510710.3109/21691401.2014.955107 ↗
27. 10.1002/art.178015060410.1002/art.1780150604 ↗
28. 10.1021/nl202559p10.1021/nl202559p ↗
29. 10.1021/ed081p544A10.1021/ed081p544A ↗
30. 10.1186/ar74810.1186/ar748 ↗
31. Holmdahl R, Carlsen S, Mikulowska A, et al. Genetic analysis of murine models for rheumatoid arthritis. In: Adolpho KW, editor. Human genome methods. New York: CRC Press; 1998. p. 215–238.
32. 10.1016/0009-8981(78)90081-510.1016/0009-8981(78)90081-5 ↗
33. 10.1016/0003-2697(69)90064-510.1016/0003-2697(69)90064-5 ↗
34. Hyc A, Osiecka-Iwan A, Dziunycz P, et al. Preparation of rat synovial membrane for studies of cytokine secretion. Folia Histochem Cytobiol. 2007;45:57–60.
35. 10.1016/j.cbi.2011.04.00710.1016/j.cbi.2011.04.007 ↗
36. 10.1172/JCI6948510.1172/JCI69485 ↗
37. Zhang L, Sun T, Yu E, et al. TNF-α expression, not iNOS expression, is correlated with NF-κB activation in the spinal cord of rats following peripheral nerve injury. Afr J Biotechnol. 2011;10:6372–6380.
38. 10.1136/gut.2003.02147710.1136/gut.2003.021477 ↗
39. Azizian M, Bathaie SZ, Ashrafi M, et al. Investigation of p53 and p27 expressions in the N-nitroso-N-methylureainduced breast cancer in female Wistar Albino rats. Physiol Pharmacol. 2014;18:337–346.
40. 10.1006/abio.2000.475310.1006/abio.2000.4753 ↗
41. 10.1002/marc.20030009310.1002/marc.200300093 ↗
42. 10.3390/s712329910.3390/s7123299 ↗
43. 10.1002/art.2240110.1002/art.22401 ↗
44. 10.1007/BF0321558810.1007/BF03215588 ↗
45. 10.4103/2231-4040.7225410.4103/2231-4040.72254 ↗
46. Bendele A. Animal models of rheumatoid arthritis. J Musculoskelet Neuronal Interact. 2001;1:377–385.
47. El-Ansary MR, Eldin TAS, Ali OMS, et al. Functionalized gold nanoparticles for inhibition of vascular endothelial growth factor in arthritic patients. J Nanomed Res. 2015;2:00036.
48. 10.1378/chest.112.6_Supplement.321S10.1378/chest.112.6_Supplement.321S ↗
49. 10.1038/nrd117510.1038/nrd1175 ↗
50. 10.3109/0785389970900747410.3109/07853899709007474 ↗
51. 10.1002/1529-0131(200006)43:6<1266::AID-ANR9>3.0.CO;2-P10.1002/1529-0131(200006)43:6<1266::AID-ANR9>3.0.CO;2-P ↗
52. 10.1186/ar230410.1186/ar2304 ↗
53. 10.1016/j.phymed.2014.02.00110.1016/j.phymed.2014.02.001 ↗
54. 10.3892/mmr.2017.738910.3892/mmr.2017.7389 ↗
55. 10.1007/s00296-001-0163-x10.1007/s00296-001-0163-x ↗
56. 10.1271/bbb.10037510.1271/bbb.100375 ↗
57. 10.1002/smll.20040009310.1002/smll.200400093 ↗